Wegovy vs Ozempic: What's the Difference?

If you've researched weight loss medications, you've likely encountered both Wegovy and Ozempic. The confusion is understandable; both are made by Novo Nordisk, both contain semaglutide, and both produce significant weight loss. So what's the difference, and which should Nigerian patients consider?

The Short Answer

Wegovy and Ozempic are essentially the same medication packaged differently for different purposes:

• Ozempic: Approved for type 2 diabetes, with maximum dose of 2mg
• Wegovy: Approved specifically for weight management, with maximum dose of 2.4mg

Both contain semaglutide. The higher Wegovy dose was specifically studied and approved for obesity treatment, while Ozempic's weight loss effects are technically "off-label" since it's only approved for diabetes.

Detailed Comparison

Why Does the Dose Difference Matter?

The 0.4mg difference between Ozempic's maximum (2mg) and Wegovy's maximum (2.4mg) may seem small, but clinical data shows it matters:

The additional 0.4mg in Wegovy contributes meaningfully to weight loss outcomes. Clinical studies demonstrate dose-dependent efficacy across the range.

Dosing Schedules Compared

Both medications use gradual titration to minimize side effects, but Wegovy has additional intermediate doses:

The 1.7mg intermediate dose in Wegovy allows for gentler escalation to the higher maximum, which can help with tolerability. For detailed dosing information, see our semaglutide dosing guide.

Clinical Trial Evidence

Ozempic: SUSTAIN Trials

The SUSTAIN trials studied semaglutide in patients with type 2 diabetes. Weight loss was a secondary endpoint. Results showed:

• Consistent weight loss of 4-6kg across trials
• Approximately 10-12% weight loss at the 1-2mg doses
• Superior to other diabetes medications for weight

Wegovy: Obesity-Specific Clinical Studies

Published clinical studies specifically evaluated semaglutide 2.4mg for weight management. Weight loss was the primary endpoint:

• Clinically significant weight loss in adults without diabetes
• Meaningful weight loss in adults with diabetes
• Enhanced results when combined with intensive behavioral therapy
• Maintenance of weight loss requires continued treatment

These studies provided the evidence needed for Wegovy's obesity indication approval. For more on expected results, see our GLP-1 weight loss timeline.

Side Effects: Any Difference?

Since both contain semaglutide, side effect profiles are nearly identical:

• Nausea, vomiting, diarrhea, constipation
• Abdominal pain, decreased appetite
• Injection site reactions (minor)
• Rare: pancreatitis, gallbladder issues

The higher Wegovy dose may produce slightly more GI symptoms initially, but the extended titration helps compensate. Our guide on managing GLP-1 nausea covers strategies that work for both medications.

Which Should You Choose?

Consider Ozempic If:

• You have type 2 diabetes (it's specifically approved for this)
• You need something that may be more accessible
• Insurance or availability favors Ozempic
• Your provider prefers the lower maximum dose
• You achieve good results at 1-2mg without needing the higher dose

Consider Wegovy If:

• Weight management is your primary goal
• You want the officially approved obesity indication
• You need the higher 2.4mg dose for maximum effect
• You prefer the gentler titration with the 1.7mg step

Access in Nigeria

Neither brand-name Ozempic nor Wegovy holds NAFDAC registration in Nigeria. For Nigerian patients, the practical considerations are:

• Compounded semaglutide: Available through some licensed providers. Can be dosed up to 2.4mg similar to Wegovy.
• International access: Both brands may be available through medical tourism or international telehealth services.
• The brand name matters less: When using compounded semaglutide, your provider can prescribe any dose, making the Ozempic vs Wegovy distinction less relevant.

For complete access information, see how to access GLP-1 medications in Nigeria.

Can You Switch Between Them?

Yes, switching between Ozempic and Wegovy is straightforward since they both contain semaglutide:

• Match the dose when switching (e.g., Ozempic 1mg to Wegovy 1mg)
• If increasing dose, follow standard titration
• No "washout" period needed between switching
• Continue on your regular injection day

How They Compare to Tirzepatide

While this article focuses on semaglutide products, it's worth noting that tirzepatide (Mounjaro/Zepbound) represents a different medication entirely:

• Tirzepatide is a dual GLP-1/GIP agonist, not just GLP-1
• Published research suggests greater weight loss with tirzepatide
• It's a separate decision from the Ozempic vs Wegovy question

For a full comparison, see our article on Ozempic vs Mounjaro.

The Bottom Line

Wegovy and Ozempic are essentially the same medication with different packaging and approved uses. Wegovy offers a higher maximum dose and is specifically approved for weight management, while Ozempic was first approved for diabetes.

For most Nigerian patients, the distinction matters less than accessing quality semaglutide with proper medical supervision. Whether you end up with branded Ozempic, branded Wegovy, or compounded semaglutide, the active ingredient doing the work is identical.

Focus on finding a reputable provider who can guide your dosing appropriately and provide ongoing monitoring, rather than fixating on which brand name appears on the packaging.